Dear colleagues, hello! 👋
A special welcome to the 40 new members who have joined our Let’s Talk Risk! community in the first week of April! Feel free to browse past articles in the archive section of the Let’s Talk Risk! website, and check out recordings of recent LTR conversations in the podcast section.
Here are links to articles published this week.
Announcements
Special offer - save 20% on annual subscription
Enjoying the free content on Let’s Talk Risk!? Upgrade your subscription with this special offer to enjoy even more benefits:
1️⃣ Premium articles: Case studies of FDA warning letters, recalls, ISO 14971 fundamentals, medical device news updates.
2️⃣ Monthly LTR webinar: Build deeper knowledge of risk management and get your specific questions answered.
3️⃣ 20% off training: You get automatic 20% off on training and coaching offers via ACHIEVE.
4️⃣ Exclusive monthly podcast: Gain insights from industry leading voices
5️⃣ Ability to start a discussion thread on LTR Chat!
Check out our Wall of Love to see what others are saying!
LTR weekly conversation on LinkedIn: A physician’s view on AI in healthcare
Join me next Friday, April 12, 2024 at 11:00 AM EST, for another Let’s Talk Risk! conversation on LinkedIn. My guest this week is Dr. Niranjan Seshadri, who will share his perspectives as an interventional cardiologist on AI in healthcare.
Ask a risk management question
Got a risk management question? Now you can submit your question and get answers through a new feature on Let’s Talk Risk!. If I pick your question for an AMA article, you will get free access to premium content for 30 days!
Weekly Knowledge Challenge
I hope you enjoyed the knowledge challenge question last week. Here is the correct answer:
The correct answer for the question, “A hazard always leads to harm” is False.
Here is this weeks’ knowledge challenge #28
1-Question Feedback Survey
Want to share feedback? Send a message to me!
If you are finding value in LTR, please give us a shout out and show your love🙏
LTR Weekly Digest #31 - 6th April, 2024